Addnok Sublingual tablet
Prescription Required
Product introduction
Addnok Sublingual tablet is used to treat moderate to severe pain and drug dependence/addiction to opioids. It helps prevent withdrawal symptoms that may be caused due to withdrawal of other opioids.
Addnok Sublingual tablet should be taken in the dose and duration as advised by your doctor. Never take this medicine in greater amounts or more often than prescribed. It can be taken with or without food but should be taken at a fixed time. If you miss a dose take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
Vomiting, dizziness, nausea, headache, difficulty sleeping and constipation are some of the common side effects that might be observed on taking this medicine. Some people may also experience anxiety, orthostatic hypotension (sudden decrease in blood pressure on standing) and diarrhea. Use caution while driving or using any machinery as it might cause drowsiness or visual disturbances.
Addnok Sublingual tablet should be taken in the dose and duration as advised by your doctor. Never take this medicine in greater amounts or more often than prescribed. It can be taken with or without food but should be taken at a fixed time. If you miss a dose take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
Vomiting, dizziness, nausea, headache, difficulty sleeping and constipation are some of the common side effects that might be observed on taking this medicine. Some people may also experience anxiety, orthostatic hypotension (sudden decrease in blood pressure on standing) and diarrhea. Use caution while driving or using any machinery as it might cause drowsiness or visual disturbances.
Uses of Addnok Sublingual tablet
- Opioid (Morphine) dependence
- Moderate to severe pain
Side effects of Addnok Sublingual tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Addnok
- Headache
- Back pain
- Drowsiness
- Vomiting
- Insomnia (difficulty in sleeping)
- Dizziness
- Abdominal pain
- Weakness
- Sweating
- Constipation
- Withdrawal syndrome
- Infection
- Vertigo
- Inflammation of the nose
- Chills
- Flu-like symptoms
- Nausea
How to use Addnok Sublingual tablet
Place the tablet under the tongue or between the cheek and gum, and let it dissolve. Do not chew, crush, or swallow the tablet. Addnok Sublingual tablet may be taken with or without food, but it is better to take it at a fixed time.
How Addnok Sublingual tablet works
Addnok Sublingual tablet is a opioid partial agonist. It prevents withdrawal symptoms in patients who stop taking opioid drugs by producing similar effects to these drugs. It also provides pain relief by acting on specific receptors in the brain that change how your body feels and responds to pain.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Addnok Sublingual tablet.
Pregnancy
CONSULT YOUR DOCTOR
Addnok Sublingual tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Addnok Sublingual tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Addnok Sublingual tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CAUTION
Addnok Sublingual tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Addnok Sublingual tablet may be needed. Please consult your doctor.
Liver
CAUTION
Addnok Sublingual tablet should be used with caution in patients with liver disease. Dose adjustment of Addnok Sublingual tablet may be needed. Please consult your doctor.
Use of Addnok Sublingual tablet is not recommended in patients with serious liver disease.
Use of Addnok Sublingual tablet is not recommended in patients with serious liver disease.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Addnok Sublingual tablet
₹79/Sublingual tablet
Sangesic 0.2 Sublingual tablet
Rusan Healthcare
₹90/sublingual tablet
12% costlier
Quick tips
- Take it at the same time every day to help you remember to take it.
- To lower the chance of feeling dizzy or passing out, rise slowly if you have been sitting or lying down.
- Use caution while driving or doing anything that requires concentration as Addnok Sublingual tablet can cause dizziness and sleepiness.
- Avoid drinking alcohol or taking other medicines that can cause drowsiness.
- Discontinue the medicine and inform your doctor if you experience difficulty breathing.
- Do not stop taking Addnok Sublingual tablet without talking to your doctor first as it may cause a worsening of symptoms.
- Your doctor may get regular blood tests to check for liver function while taking this medicine.
Fact Box
Chemical Class
Phenanthrenes Derivatives
Habit Forming
.
Therapeutic Class
NEURO CNS
Action Class
Opioids- Partial agonist
Patient concerns
FAQs
Is Addnok Sublingual tablet an opiate/ opiate blocker/ controlled substance/ pain killer/ addictive?
Addnok Sublingual tablet belongs to a class of medications called opioid partial agonist-antagonists, which is used to relieve pain. It is a controlled substance and an addictive drug. Consult your doctor for alternate drug if you experience addiction
Does Addnok Sublingual tablet block opiates?
Yes. Addnok Sublingual tablet block opiates
Can Addnok Sublingual tablet cause depression?
Addnok Sublingual tablet is not known to cause depression. If you experience such side effects, please consult your doctor.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Schumacher MA, Basbaum AI, Way WL. Opioids Analgesics & Antagonists. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 546-47.
- Yaksh TL, WallaceIn MS. Opioids, Analgesia, and Pain Management. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 510.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 165-67.
- Drugs.com. Buprenorphine. [Accessed 02 Apr. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 02 Apr. 2019] (online) Available from:
Marketer details
Name: Rusan Pharma Ltd
Address: 58-D, Government Industrial Estate, Charkop, Kandivli (W), Mumbai – 400 067 (India).
Country of origin: India
Lab tests offered by us
Related/Popular tests
174 people bought this recently₹79
Inclusive of all taxes
MRP₹80 1% OFF
20.0 Sublingual tablet in 1 strip
SOLD OUT
Notify me
